Dolocarp flavour, 20 mg, chewable tablets for dogs
Dolocarp flavour, 20 mg, chewable tablets for dogs
Authorised
- Carprofen
Product identification
Medicine name:
Dolocarp flavour, 20 mg, chewable tablets for dogs
Active substance:
- Carprofen
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Carprofen20.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AE91
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID1) 100 Chewable tablet: unspecified outer container with 1 Bottle (high-density polyethylene) with 100 Chewable tablet, closed with Closure (polypropylene)
- (ID2) 20 Chewable tablet: unspecified outer container with 1 Bottle (high-density polyethylene) with 20 Chewable tablet, closed with Closure (polypropylene)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- aniMedica GmbH
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V425932
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0142/001
Concerned member states:
-
Austria
-
Belgium
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovenia
-
Spain
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
2401365-paren-20160420.pdf
English (PDF)
Download Published on: 17/02/2026